Javascript must be enabled to continue!
Data from Degradation of Tob1 Mediated by SCF<sup>Skp2</sup>-Dependent Ubiquitination
View through CrossRef
<div>Abstract<p>Tob1, a member of the Tob/BTG family, is involved in the control of G<sub>1</sub>-S progression by suppressing cyclin D1 expression and acts as a tumor suppressor gene. Tob1 was reported to have a quick turnover through the ubiquitin-proteasome pathway, but proteins involved in this process are still unknown. We showed that Skp2, a substrate-targeting subunit of the SCF (Skp1/Cul1/F-box protein) ubiquitin ligase complex, was involved in ubiquitin-dependent degradation of Tob1. Skp2 interacted with Tob1 and facilitated ubiquitination of Tob1 in intact cells as well as <i>in vitro</i>. Skp2 mutants without the F-box or leucine rich repeat were not able to bind to Tob1 and did not enhance ubiquitination of Tob1. Tob1 was stabilized in both Skp2<sup>−/−</sup> mouse fibroblasts and Skp2 knockdown HeLa cells. Moreover, cyclin D1 expression was suppressed in Skp2 knockdown HeLa cells. These data suggest that Tob1 is a novel target for degradation by the SCF-Skp2 ubiquitin ligase. (Cancer Res 2006; 66(17): 8477-83)</p></div>
American Association for Cancer Research (AACR)
Title: Data from Degradation of Tob1 Mediated by SCF<sup>Skp2</sup>-Dependent Ubiquitination
Description:
<div>Abstract<p>Tob1, a member of the Tob/BTG family, is involved in the control of G<sub>1</sub>-S progression by suppressing cyclin D1 expression and acts as a tumor suppressor gene.
Tob1 was reported to have a quick turnover through the ubiquitin-proteasome pathway, but proteins involved in this process are still unknown.
We showed that Skp2, a substrate-targeting subunit of the SCF (Skp1/Cul1/F-box protein) ubiquitin ligase complex, was involved in ubiquitin-dependent degradation of Tob1.
Skp2 interacted with Tob1 and facilitated ubiquitination of Tob1 in intact cells as well as <i>in vitro</i>.
Skp2 mutants without the F-box or leucine rich repeat were not able to bind to Tob1 and did not enhance ubiquitination of Tob1.
Tob1 was stabilized in both Skp2<sup>−/−</sup> mouse fibroblasts and Skp2 knockdown HeLa cells.
Moreover, cyclin D1 expression was suppressed in Skp2 knockdown HeLa cells.
These data suggest that Tob1 is a novel target for degradation by the SCF-Skp2 ubiquitin ligase.
(Cancer Res 2006; 66(17): 8477-83)</p></div>.
Related Results
Data from Degradation of Tob1 Mediated by SCF<sup>Skp2</sup>-Dependent Ubiquitination
Data from Degradation of Tob1 Mediated by SCF<sup>Skp2</sup>-Dependent Ubiquitination
<div>Abstract<p>Tob1, a member of the Tob/BTG family, is involved in the control of G<sub>1</sub>-S progression by suppressing cyclin D1 expression and acts...
High Skp2/Low p57
Kip2
Expression is Associated with Poor Prognosis in Human Breast Carcinoma
High Skp2/Low p57
Kip2
Expression is Associated with Poor Prognosis in Human Breast Carcinoma
Downregulation of p57
Kip2
is involved in tumor progression, and S-phase kinase-associated protein 2 (Skp2) is an E3 ligase that regulates a...
Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF)
Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF)
Cell adhesion is essential for cell cycle progression in most normal cells. Loss of adhesion dependence is a hallmark of cellular transformation. The F-box protein Skp2 (S-phase ki...
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
Abstract
Purpose: Skp2 is a subunit of the SCF ubiquitin protein ligase, which plays a vital role in the control of tumorigenesis via its regulation of G1-S transiti...
Abstract 1805: LSD1 regulation of SKP2 expression in prostate cancer.
Abstract 1805: LSD1 regulation of SKP2 expression in prostate cancer.
Abstract
Prostate carcinogenesis is a complicated process involving both genetic and epigenetic changes. Aberrant expression of LSD1 (Lysine-specific demethylase 1) ...
The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells
The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells
Abstract
Introduction
Loss of the cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in breast cancer. The decr...
Establishment of High-throughput Screening HTRF Assay for Identification Small Molecule Inhibitors of Skp2-Cks1
Establishment of High-throughput Screening HTRF Assay for Identification Small Molecule Inhibitors of Skp2-Cks1
Abstract
S-phase kinase associated protein 2 (Skp2), a member of the F-box family that constitute the largest known class of ubiquitin E3 specificity components, is respons...
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has rema...

